A novel angucycline-type antibiotic, warkmycin, was isolated from the culture filtrate of Streptomyces strain Acta 2930. Its chemical structure was elucidated by HR-MS, one-dimensional and 2D NMR experiments. The compound inhibits the growth of Gram-positive bacteria and shows a strong antiproliferative activity against mouse fibroblast cell line NIH-3T3 and human cancer cell lines HepG2 and HT29.
INTRODUCTION
Our screening of alkaliphilic and alkalitolerant Streptomyces strains isolated from alkaline soil samples collected from the Counties of Durham and Northumberland, UK, resulted in the detection and characterization of novel secondary metabolites with antibiotic and antitumor properties, as exemplified by our reports on lactonamycin Z, pyrocoll, elloxazinones and genoketides. [2] [3] [4] [5] HPLC-diode array analysis was applied to the metabolic profiling of extracts from culture filtrates and mycelia of these streptomycetes, following growth in various complex broth media. 6 HPLC-diode array evaluation was carried out by means of our in-house HPLC-UVvis database, which contains nearly 1000 reference compounds, mostly antibiotics. 7 Two peaks in the HPLC chromatogram of the culture filtrate extract of Streptomyces strain Acta 2930 grown in oatmeal medium showed characteristic UV-vis spectra. One of them with a retention time of 8.6 min was identified as the antifungal and antitumor antibiotic actiphenol, 8 according to an identical retention time and UV-vis spectrum to the reference compound. The second peak had a retention time of 8.3 min and showed an UV-vis spectrum similar, but not identical, to various anthraquinone reference compounds held in the database. This report deals with the classification and fermentation of the producing strain, and with the isolation, structural elucidation and biological activities of warkmycin A (1), a compound that was characterized as a novel antibiotic of the angucycline family. Its structure is shown in Figure 1 .
RESULTS

Classification of the producing strain
Strain Acta 2930 produced a pale-yellowish aerial spore mass and a yellow-brown pigmented substrate mycelium on ISP-2 agar; 9 diffusible pigments were not detected. Whole-cell hydrolysates of the strain contained LL-diaminopimelic acid while the cellular fatty acid profile was rich in iso-and anteiso-branched chain components with predominant amounts of C 15:0 and iso-C 16:0 . The major isoprenologues were hexa-and octahydrogenated menaquinones with nine isoprene units. All of these properties are consistent with the classification of the strain in the genus Streptomyces, 10 an assignment supported by the partial sequencing of the 16S rRNA gene.
Screening, fermentation and isolation Strain Acta 2930 was one of a collection of filamentous actinomycetes, which were isolated from alkaline soil samples collected from a steel waste tip soil at Consett, County Durham, from a pine forest soil at Hamsterley Forest, County Durham, and from a sand dune at Warkworth, County Northumberland, UK. The strains were grown in various complex media in shake flasks and samples were separated by centrifugation into mycelia and corresponding supernatants. Extracts were analyzed by gradient-mode reversed-phase HPLC and diode array monitoring. Strain Acta 2930 was of interest because of the presence of a characteristic peak in the HPLC chromatogram that was not identified by means of our HPLC-UV-vis database but which showed a similarity in its UV-visible spectrum to those of anthraquinone reference compounds. HPLC-ESI-MS analysis revealed a molecular mass of 1049.5 Da but this did not allow for an unambiguous identification in a DNP database 11 search. Consequently, strain Acta 2930 was grown in 10-l stirred tank fermentors using a complex medium. The culture reached a maximal biomass of 8 vol-% after 48 h of incubation, the highest yield of warkmycin (1) was produced in 20 mg l À1 after an incubation period of 64 h. Compound 1 was isolated from the culture filtrate by Amberlite XAD-16 column chromatography followed by ethyl acetate extraction. The raw product was purified by subsequent chromatographic steps on Sephadex LH-20 and Toyopearl HW-40S columns. After concentration to dryness 60 mg of 1 were obtained as a yellow powder. Under acidic separation conditions using 1% CH 3 COOH in MeOH as eluent, compound 1 was completely decomposed to the deacetylated product 2. Compound 2 was not detected in the fermentation broth.
Structural determination
The molecular formula of 1 was established as C 50 H 67 NO 23 by highresolution ESI MS. Combination of the 13 C-NMR data including DEPT spectrum and a HSQC-NMR spectrum, indicated nine methyl signals, five methylene signals, twenty-one methine signals (including three anomeric carbons) and fifteen quarternary carbons ( 12 All these signals were finally assigned to an angucycline core structure. The assignment of the HMBC correlations ( Figure 2 ) confirmed the angucycline scaffold and also proved the attachment of substituents to the angucycline, that is, a methyl group to C3 and two acetoxy groups to C4 and C5, respectively. In addition, three anomeric carbons at d C 99.3, 99.8 and 103.2 were observed in the 13 C-NMR spectrum suggesting that compound 1 comprised three glycosidic linkages and therefore the presence of at least three sugar moieties.
A more detailed analysis of one-dimensional (1D) and 2D NMR data of 1 revealed the presence of four sugar moieties, provisionally termed sugars A, B, C and D (Figure 1 Table 1 ).
The substituents of sugar A were determined by COSY and HMBC correlations as shown in Figure 2 . In addition, the comparatively small coupling constant of H-1A at d The coupling constant of H-1B (J ¼ 10.7 Hz) revealed an axial position of H-1B. Furthermore, NOESY correlations between H-1B and H-3B/H-5B, between H-6B and H-5B showed H-6B and the hydroxy group at H-5B to be equatorial ( Figure 3 ). These findings determined the constitution of sugar B as b-C-olivose bound to C9 of the angucycline system.
In a similar manner, sugar C was established as a b-olivomycose. This was corroborated by NOESY correlations between H-1C and H-5C, between the methyl protons at C3 and H-4C, between H-4C and H-6C (Figure 3) . Hence, the coupling constant of H-4C (J ¼ 9.8 Hz) reveals axial orientation of H-4C. An HMBC correlation from H-3B to C1 of sugar C established the glycosidic linkage from sugar C to sugar B.
As mentioned before the large coupling constant of H-1D and in combination with the NOE correlation to H-4C are characteristic of an b-glycosidically bound sugar D. NOEs correlations from H-1D to H-3D ax /H-5D and NOEs correlations between the equatorial proton H-3D eq and H-4D, and between H-4D and H-6D revealed equatorialaxial positions of the OH group and the methyl group (H-6D) and therefore determined sugar D as b-amicetose (Figure 3 ). HMBC A novel angucycline antibiotic SE Helaly et al correlations from H-1D to C-4C and from H-4C to C-1D revealed an O-glycosidic linkage between sugar D and sugar C. In summary, 1D and 2D NMR data established compound 1 in its relative configuration as novel member of the angucycline antibiotics, named warkmycin. Compound 2 was obtained during the separation of compound 1 under acidic conditions. The molecular formula of compound 2 was determined as C 48 H 65 NO 22 by means of high-resolution ESI MS. The mass difference between compound 2 and compound 1 is 42 Da (C 2 H 2 O), suggesting the lack of the acetyl group in compound 2. 1 H-and 13 C-NMR data of 2 showed high similarity to those of compound 1 (Table 1) . Nevertheless, slight differences in the spectra were observed. 13 C-NMR of compound 2 revealed one signal in the region between 170 and 175 p.p.m. while two signals were observed in the same region of the 13 C-NMR spectrum of compound 2. Likewise, the 1H NMR spectrum of compound 2 lacks a singlet signal at d H 2.10, which was assigned to a methyl group in 1. These findings confirmed the absence of the acetyl group in compound 2 attached to C4 of the angucycline core. Besides the 2D NMR data of 2 including COSY, HSQC, HMBC and NOESY experiments were very similar to those of compound 1 and clearly confirmed the suggested structure of 2. In conclusion, the structure of compound 2 termed 4-Odeacetyl-warkmycin was established as the deacetylation product of 1. Table 2 illustrates the physico-chemical data of warkmycin (1) and 4-O-deacetyl-warkmycin (2).
Biological activity
Compounds 1 and 2 showed weak antibacterial activity against the Gram-positive bacterium Staphylococcus lentus; growth inhibition of 23% and 26%, respectively, was observed at a concentration of 100 mM. Both compounds fully inhibited the growth of Bacillus subtilis at the same concentration. Gram-negative bacteria were not susceptible to 1 and 2 at this concentration.
Furthermore, the two compounds exhibited remarkable antiproliferative activity against mouse fibroblast cell line NIH-3T3 and human cancer cell lines HepG2 and HT29. Interestingly; compound 1 exhibited more than a 12-fold potent activity against the fibroblast cell line, whereas both compounds showed similar antiproliferative activity against the cancer cell lines (Table 3) .
DISCUSSION
Warkmycin (1) belongs to the family of angucycline antibiotics, which is known to include a vast number of representatives. The angucyclines were reviewed by Rohr and Thiericke 15 and defined as compounds with an angular tetracyclic (benz[a]anthracene) moiety and hydrolyzable sugar moieties. 15 Angucyclines are distinguished by a variety of biological activities, including antitumor, antibacterial and enzyme inhibitory activities, from which the antitumor activity is the most interesting and most common action. Important representatives of the angucyclines are the landomycins. 16 They display a single deoxyoligosaccharide chain of various lengths with up to six carbohydrates, as for landomycin A. Accordingly, the carbohydrate composition of landomycin is a repeated sequence of b-D-olivose-(4-1)-b-D-olivose-(3-1)-a-L-rhodinose attached to a phenolic oxygen of the angucycline core. The biological activities were mainly found to be dependent on the length of the saccharide chain. 12 Other examples of angucyclines are the antitumor drugs urdamycin A and B of the aquayamycin-type. Urdamycins display C-glycosylation with three sugar moieties at C9 as a characteristic structural feature. 17 Urdamycin A displays two glycosylation positions, at C9 with b-D-olivose-(3-1)-a-L-rhodinose-(4-1)-b-D-olivose and at 12b with L-rhodinose. Because of the presence of an angular oxygen and C-and O-glycosidic moieties, warkmycin (C 50 H 67 NO 23 , 1) also belongs to the aquayamycin-type of angucyclines with angular oxygens and a C-glycosidic moiety. 17 Like urdamycin, warkmycin also shows a C-glycosylation at C9 with three sugar moieties. 
METHODS
Producing strain
A soil sample was collected from an embryo sand dune at Warkworth, Northumberland, UK. Strain Acta 2930 was isolated from the sandy soil sample on starch-casein agar 18 adjusted to pH 10.5 (1 M NaOH) and was preserved as a mixture of spores and mycelial fragments in glycerol (20% vol vol À1 ) at À20 1C. The strain is deposited in the strain collection of the School of Biology at Newcastle University, Newcastle upon Tyne, UK. It was examined for chemotaxonomic and morphological properties known to be of value in streptomycete systematics, 19 and by partial 16S rRNA gene sequence analysis.
HPLC screening
The HPLC system consisted of an HP 1090M liquid chromatograph equipped with a diode array detector and an HP Kayak XM 600 ChemStation (Agilent Technologies, Waldbronn, Germany). Sample preparation and chromatographic conditions were performed as described earlier. 20 HPLC-ESI-MS analysis was done with an Agilent 1200 HPLC series equipped with a diode array detector and a LC/MSD Ultra Trap System XCT 6330 (Agilent Technologies). Samples (2.5 ml) were injected onto an HPLC column (Nucleosil-100 C-18, 3 mm, 100 Â 2 mm; Maisch, Ammerbuch, Germany) and separated by 0.1% aqueous HCOOH as solvent A and 0.06% HCOOH in CH 3 CN as solvent B by a linear gradient from 10 to 100% B over 15 min at a flow rate of 400 ml min À1 . Hyphlo Super-cel (2%; Johns-Manville, Denver, CO, USA) was added to the fermentation broths of two 10-l fermentations, which were separated by multiple sheet filtration into culture filtrate and mycelium. Nineteen liters of culture filtrates were applied to an Amberlite XAD-16 (Rohm and Haas, Frankfurt, Germany) column (resin volume 2 l), and the resin washed with H 2 O and H 2 O-MeOH (1:1). Compound 1 was eluted with 100% MeOH and concentrated in vacuo to an aqueous residue (500 ml). The concentrate was adjusted to pH 4.0 and extracted twice with EtOAc (each 100 ml), and the organic extracts combined and concentrated in vacuo to dryness. The crude product (370 mg) was dissolved in MeOH and purified by Sephadex LH-20 (Amersham, Freiburg, Germany) and Toyopearl TSK HW-40 (Tosoh, Stuttgart, Germany) chromatography (each column 90 Â 2.5 cm) with MeOH as eluent at a flow rate of 30 ml h À1 . After concentration in vacuo to dryness, compound 1 was obtained as a yellow powder with a yield of 60 mg.
Fermentation and isolation
Structural determination
High-resolution ESI-MS mass spectra were recorded using a LTQ-Orbitrap XL (Thermo Scientific, Bremen, Germany) coupled to an Agilent 1260 HPLC system (Agilent Technologies). NMR spectra were recorded on a DRX 500 spectrometer (Bruker, Karlsruhe, Germany) equipped with a broadband inverse detection probe head with z gradients at 500 and 125 MHz for 1 H and 13 C, respectively. CDCl 3 was used as a solvent for NMR experiments and chemical shifts were referenced to the solvent peaks (7.24 p.p.m. 
Antimicrobial assays
Antimicrobial assays were performed using the Gram-positive bacteria Bacillus subtilis DSM 347 and Staphylococcus lentus DSM 6672, and Gram-negative bacteria Escherichia coli K12 (W1130) and Pseudomonas fluorescens DSM 50090. The growth inhibition was characterized by determining the cell viability using a fluorescence based resazurin assay as described by Schulz et al. 21 
Cytotoxicity assays
The sensitivity of the cell lines NIH-3T3 (kindly provided by G Rimbach, Universität Kiel, Germany), HepG2 and HT29 to warkmycin was evaluated by monitoring the metabolic activity using the CellTiter-BlueCell Viability Assay (Promega, Mannheim, Germany). Cultivation and the bioassays were performed as described by Schulz et al. 21 Tamoxifen has been used as a reference compound.
